Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 230
Filter
1.
J Vet Cardiol ; 48: 46-53, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37433242

ABSTRACT

A 6-year-old female spayed Chihuahua mix presented with chronic recurrent ascites. Computed tomographic angiography revealed an isolated stenosis of the caudal vena cava secondary to a metallic foreign body, resulting in Budd-Chiari-like syndrome. Balloon angioplasty and endovascular stent placement successfully resolved the obstruction with long-term resolution of ascites.


Subject(s)
Angioplasty, Balloon , Budd-Chiari Syndrome , Dog Diseases , Wounds, Gunshot , Female , Dogs , Animals , Wounds, Gunshot/complications , Wounds, Gunshot/veterinary , Ascites/veterinary , Stents/veterinary , Budd-Chiari Syndrome/diagnostic imaging , Budd-Chiari Syndrome/therapy , Budd-Chiari Syndrome/veterinary , Angioplasty, Balloon/veterinary , Dog Diseases/diagnostic imaging , Dog Diseases/therapy
2.
Vaccine ; 40(46): 6640-6648, 2022 11 02.
Article in English | MEDLINE | ID: mdl-36210254

ABSTRACT

BACKGROUND: Studies on sociodemographic disparities in Covid-19 vaccination uptake in the general population are still limited and mostly focused on older adults. This study examined sociodemographic differences in Covid-19 vaccination uptake in the total Swedish population aged 18-64 years. METHODS: National Swedish register data within the SCIFI-PEARL project were used to cross-sectionally investigate sociodemographic differences in Covid-19 vaccination among Swedish adults aged 18-64 years (n = 5,987,189) by 12 October 2021. Using logistic regression models, analyses were adjusted for sociodemographic factors, region of residence, history of Covid-19, and comorbidities. An intersectional analysis approach including several cross-classified subgroups was used to further address the complexity of sociodemographic disparities in vaccination uptake. FINDINGS: By 12 October 2021, 76·0% of the Swedish population 18-64 years old had received at least two doses of Covid-19 vaccine, an additional 5·5% had received only one dose, and 18·5% were non-vaccinated. Non-vaccinated individuals were, compared to vaccinated, more often younger, male, had a lower income, were not gainfully employed, and/or were born outside Sweden. The social patterning for vaccine dose two was similar, but weaker, than for dose one. After multivariable adjustments, findings remained but were attenuated indicating the need to consider different sociodemographic factors simultaneously. The intersectional analysis showed a large variation in vaccine uptake ranging from 32% to 96% in cross-classified subgroups, reflecting considerable sociodemographic heterogeneity in vaccination coverage. INTERPRETATION: Our study, addressing the entire Swedish population aged 18-64 years, showed broad sociodemographic disparities in Covid-19 vaccine uptake but also wide heterogeneities in coverage. The intersectional analysis approach indicates that focusing on specific sociodemographic factors in isolation and group average risks without considering the heterogeneity within such groups will risk missing the full variability of vaccine coverage. FUNDING: SciLifeLab / Knut & Alice Wallenberg Foundation, Swedish Research Council, Swedish government ALF agreement, FORMAS.


Subject(s)
COVID-19 Vaccines , COVID-19 , Humans , Male , Aged , Adolescent , Young Adult , Adult , Middle Aged , Sweden/epidemiology , COVID-19/epidemiology , COVID-19/prevention & control , Vaccination , Vaccination Coverage
3.
Neuroimage ; 260: 119390, 2022 10 15.
Article in English | MEDLINE | ID: mdl-35817295

ABSTRACT

Lower-density Electroencephalography (EEG) recordings (from 1 to approximately 32 electrodes) are widely-used in research and clinical practice and enable scalable brain function measurement across a variety of settings and populations. Though a number of automated pipelines have recently been proposed to standardize and optimize EEG pre-processing for high-density systems with state-of-the-art methods, few solutions have emerged that are compatible with lower-density systems. However, lower-density data often include long recording times and/or large sample sizes that would benefit from similar standardization and automation with contemporary methods. To address this need, we propose the HAPPE In Low Electrode Electroencephalography (HAPPILEE) pipeline as a standardized, automated pipeline optimized for EEG recordings with lower density channel layouts of any size. HAPPILEE processes task-free (e.g., resting-state) and task-related EEG (including event-related potential data by interfacing with the HAPPE+ER pipeline), from raw files through a series of processing steps including filtering, line noise reduction, bad channel detection, artifact correction from continuous data, segmentation, and bad segment rejection that have all been optimized for lower density data. HAPPILEE also includes post-processing reports of data and pipeline quality metrics to facilitate the evaluation and reporting of data quality and processing-related changes to the data in a standardized manner. Here the HAPPILEE steps and their optimization with both recorded and simulated EEG data are described. HAPPILEE's performance is then compared relative to other artifact correction and rejection strategies. The HAPPILEE pipeline is freely available as part of HAPPE 2.0 software under the terms of the GNU General Public License at: https://github.com/PINE-Lab/HAPPE.


Subject(s)
Electroencephalography , Signal Processing, Computer-Assisted , Artifacts , Electrodes , Electroencephalography/methods , Software
4.
J Vet Cardiol ; 40: 119-125, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34144877

ABSTRACT

INTRODUCTION: The study objectives were to determine the prevalence and geographic distribution of a dilated cardiomyopathy (DCM)-associated RNA-binding motif protein 20 (RBM20) variant in canine DNA samples submitted for testing and to evaluate the influence of the genotype on cardiac phenotype and lifespan. ANIMALS: Samples from 2136 dogs including 1834 Standard Schnauzers (SSNZ), 266 Giant Schnauzers (GSNZ), and 36 dogs of other breeds. METHODS: The University of Missouri Canine Genetics Laboratory's sample-accession spreadsheet and Orthopedic Foundation for Animals' database were retrospectively reviewed for samples submitted for RBM20 genotyping from November, 2013, through May, 2018. Data analyzed included breed, date of birth, RBM20 genotype (homozygous wild-type, heterozygous variant [HET], or homozygous variant [HOM]), geographic origin of submission, pedigree, cardiac phenotype, and date of death or current age if alive. RESULTS AND DISCUSSION: The RBM20 variant was only detected in SSNZ and GSNZ. A total of 389 SSNZ were variant-positive (prevalence = 21.2%), with 361 HET (19.7%) and 28 HOM (1.5%). Of the HOM SSNZ, DCM was confirmed in 26 of 28 (92.9%), with the remainder lost to follow-up. The median lifespan of HOM SSNZ (3.06 years) was significantly shorter than that for HET (15.11 years) and wild-type (15.18 years) SSNZ. Twenty-six GSNZ were variant-positive (prevalence = 9.8%), with 23 HET (8.6%) and three HOM (1.1%). Nine GSNZ belonged to one family, including the three HOM GSNZ that all had DCM. CONCLUSIONS: The HOM genotype is associated with DCM and premature death in SSNZ and GSNZ.


Subject(s)
Cardiomyopathy, Dilated , Dog Diseases , Animals , Cardiomyopathy, Dilated/epidemiology , Cardiomyopathy, Dilated/genetics , Cardiomyopathy, Dilated/veterinary , Dog Diseases/epidemiology , Dog Diseases/genetics , Dogs , Genotype , Longevity , Prevalence , RNA-Binding Motifs , Retrospective Studies
5.
Nat Commun ; 12(1): 3044, 2021 05 24.
Article in English | MEDLINE | ID: mdl-34031415

ABSTRACT

Unlike other malignancies, therapeutic options in pancreatic ductal adenocarcinoma (PDAC) are largely limited to cytotoxic chemotherapy without the benefit of molecular markers predicting response. Here we report tumor-cell-intrinsic chromatin accessibility patterns of treatment-naïve surgically resected PDAC tumors that were subsequently treated with (Gem)/Abraxane adjuvant chemotherapy. By ATAC-seq analyses of EpCAM+ PDAC malignant epithelial cells sorted from 54 freshly resected human tumors, we show here the discovery of a signature of 1092 chromatin loci displaying differential accessibility between patients with disease free survival (DFS) < 1 year and patients with DFS > 1 year. Analyzing transcription factor (TF) binding motifs within these loci, we identify two TFs (ZKSCAN1 and HNF1b) displaying differential nuclear localization between patients with short vs. long DFS. We further develop a chromatin accessibility microarray methodology termed "ATAC-array", an easy-to-use platform obviating the time and cost of next generation sequencing. Applying this methodology to the original ATAC-seq libraries as well as independent libraries generated from patient-derived organoids, we validate ATAC-array technology in both the original ATAC-seq cohort as well as in an independent validation cohort. We conclude that PDAC prognosis can be predicted by ATAC-array, which represents a low-cost, clinically feasible technology for assessing chromatin accessibility profiles.


Subject(s)
Chromatin Immunoprecipitation Sequencing/methods , Chromatin , Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/genetics , Biomarkers, Tumor , Carcinoma, Pancreatic Ductal/diagnosis , Carcinoma, Pancreatic Ductal/genetics , Carcinoma, Pancreatic Ductal/metabolism , Cell Nucleus , Hepatocyte Nuclear Factor 1-beta/genetics , High-Throughput Nucleotide Sequencing/methods , Humans , Kruppel-Like Transcription Factors/genetics , Pancreatic Neoplasms/metabolism , Prognosis , Transcription Factors , Transcriptome , Pancreatic Neoplasms
7.
Vet J ; 251: 105347, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31492386

ABSTRACT

Pulmonary hypertension (PH) is associated with substantial morbidity and if untreated, mortality. The human classification of PH is based on pathological, hemodynamic characteristics, and therapeutic approaches. Despite being a leading cause of PH, little is known about dogs with respiratory disease and/or hypoxia (RD/H)-associated PH. Therefore, our objectives were to retrospectively describe clinical features, diagnostic evaluations, final diagnoses and identify prognostic variables in dogs with RD/H and PH. In 47 dogs identified with RD/H and PH, chronic airway obstructive disorders, bronchiectasis, bronchiolar disease, emphysema, pulmonary fibrosis, neoplasia and other parenchymal disorders were identified using thoracic radiography, computed tomography, fluoroscopy, tracheobronchoscopy, bronchoalveolar lavage, and histopathology. PH was diagnosed using transthoracic echocardiography. Overall median survival was 276.0 days (SE, 95% CI; 216, 0-699 days). Dogs with an estimated systolic pulmonary arterial pressure (sPAP) ≥47mmHg (n=21; 9 days; 95% CI, 0-85 days) had significantly shorter survival times than those <47mmHg (n=16; P=0.001). Estimated sPAP at a cutoff of ≥47mmHg was a fair predictor of non-survival with sensitivity of 0.78 (95% CI, 0.52-0.94) and specificity of 0.63 (95% CI, 0.38-0.84). Phosphodiesterase-5 (PDE5) inhibitor administration was the sole independent predictor of survival in a multivariable analysis (hazard ratio: 4.0, P=0.02). Canine PH is present in a diverse spectrum of respiratory diseases, most commonly obstructive disorders. Similar to people, severity of PH is prognostic in dogs with RD/H and PDE5 inhibition could be a viable therapy to improve outcome.


Subject(s)
Dog Diseases/diagnosis , Hypertension, Pulmonary/veterinary , Hypoxia/veterinary , Respiration Disorders/veterinary , Animals , Dog Diseases/drug therapy , Dog Diseases/etiology , Dogs , Echocardiography/veterinary , Female , Hypertension, Pulmonary/diagnosis , Hypertension, Pulmonary/drug therapy , Hypertension, Pulmonary/etiology , Hypoxia/physiopathology , Male , Phosphodiesterase 5 Inhibitors/therapeutic use , Respiration Disorders/physiopathology , Retrospective Studies , Survival Analysis , Treatment Outcome
8.
J Vet Cardiol ; 24: 7-19, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31405557

ABSTRACT

INTRODUCTION: Canine pulmonary hypertension (PH) is associated with high morbidity and mortality. Tadalafil, a phosphodiesterase-5 inhibitor used commonly in humans with PH, has not been evaluated in a clinical trial in dogs with naturally occurring PH. Our objectives were to compare the efficacy of tadalafil and sildenafil on PH assessed by peak tricuspid regurgitant flow velocity, estimated systolic pulmonary arterial pressure gradient, voluntary activity, quality of life, and safety profiles in dogs with moderate to severe PH. ANIMALS: Twenty-three dogs with echocardiographic evidence of moderate to severe PH were enrolled. METHODS: A prospective short-term, randomized, double-blinded pilot study was carried out. Dogs with PH were randomly allocated to receive sildenafil or tadalafil for 2 weeks and assessed via echocardiography, activity monitors, and owner-reported outcomes. RESULTS: Collectively, phosphodiesterase-5 inhibition significantly decreased (improved) quality of life scores (p = 0.003) and visual analog score (p = 0.024) without significant between-treatment difference of these variables. Phosphodiesterase-5 inhibition did not significantly affect peak tricuspid regurgitant flow velocity (p = 0.056) or voluntary activity (p = 0.27). A total of 33% (7/21) of dogs experienced at least one adverse event during the study (tadalafil, n = 5; sildenafil, n = 2) with no significant difference between treatment type and incidence of adverse events (p = 0.36). DISCUSSION: In this pilot study, phosphodiesterase-5 inhibition led to apparent improvement in quality of life scores without documenting superiority of tadalafil over sildenafil. CONCLUSION: Tadalafil at a dose of 2 mg/kg once daily appears to be a viable alternative to sildenafil in dogs with moderate to severe PH.


Subject(s)
Dog Diseases/drug therapy , Hypertension, Pulmonary/veterinary , Phosphodiesterase 5 Inhibitors/therapeutic use , Animals , Dog Diseases/physiopathology , Dogs , Double-Blind Method , Electrocardiography/veterinary , Female , Hypertension, Pulmonary/drug therapy , Male , Phosphodiesterase 5 Inhibitors/administration & dosage , Pilot Projects , Prospective Studies , Random Allocation , Severity of Illness Index , Sildenafil Citrate/administration & dosage , Sildenafil Citrate/therapeutic use , Surveys and Questionnaires , Tadalafil/administration & dosage , Tadalafil/therapeutic use , Treatment Outcome
9.
Clin Radiol ; 74(8): 649.e19-649.e26, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31153596

ABSTRACT

In this review, we discuss the imaging classification of pelvic ring fractures in the context of our experience of reporting trauma computed tomography (CT) in a major trauma centre. Pelvic ring fractures are potentially significant injuries with risk of significant haemorrhage and morbidity. This review details the use of classification systems in determining the mechanism and severity of injury, with discussion of the features of the Young and Burgess classification system. We demonstrate the different types of pelvic ring fracture with examples from trauma CT, and with reference to the distribution and frequency of these injuries in trauma patients. This review will allow the reader to assess trauma CT for significant pelvic ring injury and identify features of instability.


Subject(s)
Fractures, Bone/diagnostic imaging , Pelvic Bones/diagnostic imaging , Pelvic Bones/injuries , Tomography, X-Ray Computed/methods , Trauma Centers , England , Humans
10.
Gene Ther ; 24(4): 215-223, 2017 04.
Article in English | MEDLINE | ID: mdl-28079862

ABSTRACT

CLN2 neuronal ceroid lipofuscinosis is a hereditary lysosomal storage disease with primarily neurological signs that results from mutations in TPP1, which encodes the lysosomal enzyme tripeptidyl peptidase-1 (TPP1). Studies using a canine model for this disorder demonstrated that delivery of TPP1 enzyme to the cerebrospinal fluid (CSF) by intracerebroventricular administration of an AAV-TPP1 vector resulted in substantial delays in the onset and progression of neurological signs and prolongation of life span. We hypothesized that the treatment may not deliver therapeutic levels of this protein to tissues outside the central nervous system that also require TPP1 for normal lysosomal function. To test this hypothesis, dogs treated with CSF administration of AAV-TPP1 were evaluated for the development of non-neuronal pathology. Affected treated dogs exhibited progressive cardiac pathology reflected by elevated plasma cardiac troponin-1, impaired cardiac function and development of histopathological myocardial lesions. Progressive increases in the plasma activity levels of alanine aminotransferase and creatine kinase indicated development of pathology in the liver and muscles. The treatment also did not prevent disease-related accumulation of lysosomal storage bodies in the heart or liver. These studies indicate that optimal treatment outcomes for CLN2 disease may require delivery of TPP1 systemically as well as directly to the central nervous system.


Subject(s)
Aminopeptidases/genetics , Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/genetics , Genetic Therapy , Lysosomal Storage Diseases/therapy , Neuronal Ceroid-Lipofuscinoses/therapy , Serine Proteases/genetics , Aminopeptidases/therapeutic use , Animals , Dependovirus , Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/therapeutic use , Disease Models, Animal , Dogs , Gene Transfer Techniques , Genetic Vectors/genetics , Genetic Vectors/therapeutic use , Humans , Infusions, Intraventricular , Lysosomal Storage Diseases/genetics , Neuronal Ceroid-Lipofuscinoses/genetics , Neurons/metabolism , Neurons/pathology , Serine Proteases/therapeutic use , Tripeptidyl-Peptidase 1
11.
Epidemiol Infect ; 144(11): 2251-9, 2016 08.
Article in English | MEDLINE | ID: mdl-27068133

ABSTRACT

Climate change experts predict the number of nuisance-biting arthropods in England will increase but there is currently no known surveillance system in place to monitor or assess the public health impact of arthropod bites. This retrospective ecological study utilized arthropod bites requiring healthcare from five national real-time syndromic surveillance systems monitoring general practitioner (GP) consultations (in-hours and out-of-hours), emergency department (ED) attendances and telephone calls to remote advice services to determine baseline incidence in England between 2000 and 2013 and to assess the association between arthropod bites and temperature. During summer months (weeks 20-40) we estimated that arthropod bites contribute a weekly median of ~4000 GP consultations, 750 calls to remote advice services, 700 ED and 1300 GP out-of-hours attendances. In all systems, incidence was highest during summer months compared to the rest of the year. Arthropod bites were positively associated with temperature with incidence rate ratios (IRRs) that ranged between systems from 1·03 [95% confidence interval (CI) 1·01-1·06] to 1·14 (95% CI 1·11-1·16). Using syndromic surveillance systems we have established and described baseline incidence of arthropod bites and this can now be monitored routinely in real time to assess the impact of extreme weather events and climate change.


Subject(s)
Emergency Medical Services/statistics & numerical data , Insect Bites and Stings/epidemiology , Public Health , Tick Bites/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Child , Child, Preschool , Climate Change , England/epidemiology , Female , Humans , Incidence , Infant , Infant, Newborn , Insect Bites and Stings/etiology , Male , Middle Aged , Population Surveillance , Retrospective Studies , Temperature , Tick Bites/etiology , Young Adult
12.
Cell Death Differ ; 23(6): 997-1003, 2016 06.
Article in English | MEDLINE | ID: mdl-26990659

ABSTRACT

Recently it was shown that circulating Ly6C(+) monocytes traffic from tissue to the draining lymph nodes (LNs) with minimal alteration in their overall phenotype. Furthermore, in the steady state, Ly6C(+) monocytes are as abundant as classical dendritic cells (DCs) within the draining LNs, and even more abundant during inflammation. However, little is known about the functional roles of constitutively trafficking Ly6C(+) monocytes. In this study we investigated whether Ly6C(+) monocytes can efferocytose (acquire dying cells) and cross-present cell-associated antigen, a functional property particularly attributed to Batf3(+) DCs. We demonstrated that Ly6C(+) monocytes intrinsically efferocytose and cross-present cell-associated antigen to CD8(+) T cells. In addition, efferocytosis was enhanced upon direct activation of the Ly6C(+) monocytes through its corresponding TLRs, TLR4 and TLR7. However, only ligation of TLR7, and not TLR4, enhanced cross-presentation by Ly6C(+) monocytes. Overall, this study outlines two functional roles, among others, that Ly6C(+) monocytes have during an adaptive immune response.


Subject(s)
Antigens, Ly/metabolism , Monocytes/metabolism , Animals , Apoptosis/radiation effects , Basic-Leucine Zipper Transcription Factors/metabolism , Dendritic Cells/cytology , Dendritic Cells/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Confocal , Monocytes/cytology , Ovalbumin/immunology , Phagocytosis , RNA/chemistry , RNA/metabolism , Repressor Proteins/metabolism , Sequence Analysis, RNA , Spleen/cytology , Spleen/immunology , Thymocytes/cytology , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/metabolism , Toll-Like Receptor 7/genetics , Toll-Like Receptor 7/metabolism , Transcriptome , Ultraviolet Rays
13.
Oncogene ; 35(32): 4282-8, 2016 08 11.
Article in English | MEDLINE | ID: mdl-26592447

ABSTRACT

Pancreatic cancer is one of the most lethal malignancies, with virtually all patients eventually succumbing to their disease. Mutations in p53 have been documented in >50% of pancreatic cancers. Owing to the high incidence of p53 mutations in PanIN 3 lesions and pancreatic tumors, we interrogated the comparative ability of adult pancreatic acinar and ductal cells to respond to oncogenic Kras and mutant Tp53(R172H) using Hnf1b:CreER(T2) and Mist1:CreER(T2) mice. These studies involved co-activation of a membrane-tethered GFP lineage label, allowing for direct visualization and isolation of cells undergoing Kras and mutant p53 activation. Kras activation in Mist1(+) adult acinar cells resulted in brisk PanIN formation, whereas no evidence of pancreatic neoplasia was observed for up to 6 months following Kras activation in Hnf1beta(+) adult ductal cells. In contrast to the lack of response to oncogenic Kras alone, simultaneous activation of Kras and mutant p53 in adult ductal epithelium generated invasive PDAC in 75% of mice as early as 2.5 months after tamoxifen administration. These data demonstrate that pancreatic ductal cells, whereas exhibiting relative resistance to oncogenic Kras alone, can serve as an effective cell of origin for pancreatic ductal adenocarcinoma in the setting of gain-of-function mutations in p53.


Subject(s)
Adenocarcinoma/genetics , Adenocarcinoma/pathology , Mutation , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/pathology , Proto-Oncogene Proteins p21(ras)/metabolism , Tumor Suppressor Protein p53/genetics , Animals , Carcinogenesis , Cell Line, Tumor , Cellular Senescence , Humans , Mice , Phosphoproteins/metabolism , STAT3 Transcription Factor/metabolism , Signal Transduction
14.
Oncogene ; 34(50): 6029-39, 2015 Dec 10.
Article in English | MEDLINE | ID: mdl-26364615

ABSTRACT

The crucial role of the immune system in the formation and progression of tumors has been widely accepted. On one hand, the surveillance role of the immune system plays an important role in endogenous tumor prevention, but on the other hand, in some special circumstances such as in chronic inflammation, the immune system can actually contribute to the formation and progression of tumors. In recent years, there has been an explosion of novel targeted immunotherapies for advanced cancers. In the present manuscript, we explore known and potential various types of cancer prevention strategies and focus on nonvaccine-based cancer preventive strategies targeting the immune system at the early stages of tumorigenesis.


Subject(s)
Neoplasms/immunology , Neoplasms/prevention & control , Chemoprevention , Dendritic Cells/immunology , Humans , Immunotherapy , Interleukin 1 Receptor Antagonist Protein/physiology , Interleukin-6/antagonists & inhibitors , Interleukin-8/antagonists & inhibitors , Monitoring, Immunologic , Programmed Cell Death 1 Receptor/physiology , STAT3 Transcription Factor/antagonists & inhibitors , T-Lymphocytes, Regulatory/immunology , Th17 Cells/immunology
15.
Oncogene ; 34(21): 2801-6, 2015 May 21.
Article in English | MEDLINE | ID: mdl-25065594

ABSTRACT

Somatic activation of the KRAS proto-oncogene is evident in almost all pancreatic cancers, and appears to represent an initiating event. These mutations occur primarily at codon 12 and less frequently at codons 13 and 61. Although some studies have suggested that different KRAS mutations may have variable oncogenic properties, to date there has been no comprehensive functional comparison of multiple KRAS mutations in an in vivo vertebrate tumorigenesis system. We generated a Gal4/UAS-based zebrafish model of pancreatic tumorigenesis in which the pancreatic expression of UAS-regulated oncogenes is driven by a ptf1a:Gal4-VP16 driver line. This system allowed us to rapidly compare the ability of 12 different KRAS mutations (G12A, G12C, G12D, G12F, G12R, G12S, G12V, G13C, G13D, Q61L, Q61R and A146T) to drive pancreatic tumorigenesis in vivo. Among fish injected with one of five KRAS mutations reported in other tumor types but not in human pancreatic cancer, 2/79 (2.5%) developed pancreatic tumors, with both tumors arising in fish injected with A146T. In contrast, among fish injected with one of seven KRAS mutations known to occur in human pancreatic cancer, 22/106 (20.8%) developed pancreatic cancer. All eight tumorigenic KRAS mutations were associated with downstream MAPK/ERK pathway activation in preneoplastic pancreatic epithelium, whereas nontumorigenic mutations were not. These results suggest that the spectrum of KRAS mutations observed in human pancreatic cancer reflects selection based on variable tumorigenic capacities, including the ability to activate MAPK/ERK signaling.


Subject(s)
Cell Transformation, Neoplastic/genetics , Mutation/genetics , Pancreas/pathology , Proto-Oncogene Proteins/genetics , Vertebrates/genetics , ras Proteins/genetics , Animals , Cell Transformation, Neoplastic/pathology , Epithelium/pathology , Gene Expression Regulation, Neoplastic/genetics , Humans , Mitogen-Activated Protein Kinase Kinases/genetics , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/pathology , Proto-Oncogene Mas , Proto-Oncogene Proteins p21(ras) , Zebrafish/genetics
16.
Epidemiol Infect ; 142(5): 984-93, 2014 May.
Article in English | MEDLINE | ID: mdl-23902949

ABSTRACT

During 2012 real-time syndromic surveillance formed a key part of the daily public health surveillance for the London Olympic and Paralympic Games. It was vital that these systems were evaluated prior to the Games; in particular what types and scales of incidents could and could not be detected. Different public health scenarios were created covering a range of potential incidents that the Health Protection Agency would require syndromic surveillance to rapidly detect and monitor. For the scenarios considered it is now possible to determine what is likely to be detectable and how incidents are likely to present using the different syndromic systems. Small localized incidents involving food poisoning are most likely to be detected the next day via emergency department surveillance, while a new strain of influenza is more likely to be detected via GP or telephone helpline surveillance, several weeks after the first seed case is introduced.


Subject(s)
Disease Outbreaks , Models, Theoretical , Public Health Surveillance/methods , Anniversaries and Special Events , Computer Simulation , Cryptosporidiosis/epidemiology , Diarrhea , Humans , Influenza, Human/epidemiology , London/epidemiology , Sports , Time Factors , Vomiting
17.
Epidemiol Infect ; 142(1): 107-13, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23570654

ABSTRACT

This paper considers the reported attack ratio arising from outbreaks of influenza in enclosed societies. These societies are isolated from the wider community and have greater opportunities for contact between members which would aid the spread of disease. While the particular kind of society (prison, care home, school, barracks, etc.) was not a significant factor in an adjusted model of attack ratio, a person's occupation within the society was. In particular, children and military personnel suffer a greater attack ratio than other occupational types (staff, prisoners, etc.). There was no temporal trend in final attack ratio nor, with the exception of 1918, do pandemic years show abnormal attack ratios. We also observed that as community size increases, the attack ratio undergoes steep nonlinear decline. This statistical analysis draws attention to how the organization of such societies, their size and the occupations of individuals within them affect the final attack ratio.


Subject(s)
Influenza, Human/epidemiology , Influenza, Human/history , Models, Statistical , Pandemics , Social Environment , History, 19th Century , History, 20th Century , History, 21st Century , Hospitals , Humans , Military Facilities , Occupations , Prisons , Regression Analysis , Schools , Ships
18.
Dis Markers ; 35(5): 295-9, 2013.
Article in English | MEDLINE | ID: mdl-24167377

ABSTRACT

BACKGROUND AND AIMS: Fecal S100A12 is shown to be a useful noninvasive marker of gut inflammation. However, the studies to date have not characterised the patterns of expression in healthy young children. This study aimed to determine S100A12 levels in infants and children without symptoms of underlying gut disease. METHODS: Stool samples were collected from healthy infants (<12 months) and children without gastrointestinal symptoms. Faecal S100A12 was measured by immunoassay. RESULTS: Fifty-six children were recruited. Serial samples were obtained from seven term infants over the first 6 months of life. Single samples were obtained from 49 healthy children ranging from 0.16 to 13.8 years of age. Median S100A12 levels were 0.5 mg/kg (ranging from 0.39 to 25) in the healthy children, with high values (>10 mg/kg) in five infants only. There was no variation between gender. Median S100A12 levels in healthy infants remained below the established normal cut-off from birth to six months of age. CONCLUSION: S100A12 levels in well infants and children are almost exclusively lower than the standard cut-off. Transiently higher levels may be seen in early infancy. An elevated level of S100A12 in children older than 12 months of age is likely to represent organic gut disease.


Subject(s)
Feces/chemistry , S100 Proteins/analysis , Adolescent , Child , Child, Preschool , Female , Healthy Volunteers , Humans , Infant , Infant, Newborn , Male , S100A12 Protein
19.
Stat Med ; 32(20): 3522-38, 2013 Sep 10.
Article in English | MEDLINE | ID: mdl-23483594

ABSTRACT

Statistical methods used in spatio-temporal surveillance of disease are able to identify abnormal clusters of cases but typically do not provide a measure of the degree of association between one case and another. Such a measure would facilitate the assignment of cases to common groups and be useful in outbreak investigations of diseases that potentially share the same source. This paper presents a model-based approach, which on the basis of available location data, provides a measure of the strength of association between cases in space and time and which is used to designate and visualise the most likely groupings of cases. The method was developed as a prospective surveillance tool to signal potential outbreaks, but it may also be used to explore groupings of cases in outbreak investigations. We demonstrate the method by using a historical case series of Legionnaires' disease amongst residents of England and Wales.


Subject(s)
Disease Outbreaks , Legionnaires' Disease/epidemiology , Models, Statistical , Space-Time Clustering , Computer Simulation , Humans , Population Surveillance/methods , United Kingdom/epidemiology
20.
Vaccine ; 31(8): 1163-70, 2013 Feb 06.
Article in English | MEDLINE | ID: mdl-23306362

ABSTRACT

We have developed a new oral vaccine against enterotoxigenic Escherichia coli (ETEC) diarrhea containing killed recombinant E. coli bacteria expressing increased levels of ETEC colonization factors (CFs) and a recombinant protein (LCTBA), i.e. a hybrid between the binding subunits of E. coli heat labile toxin (LTB) and cholera toxin (CTB). We describe a randomized, comparator controlled, double-blind phase I trial in 60 adult Swedish volunteers of a prototype of this vaccine. The safety and immunogenicity of the prototype vaccine, containing LCTBA and an E. coli strain overexpressing the colonization factor CFA/I, was compared to a previously developed oral ETEC vaccine, consisting of CTB and inactivated wild type ETEC bacteria expressing CFA/I (reference vaccine). Groups of volunteers were given two oral doses of either the prototype or the reference vaccine; the prototype vaccine was administered at the same or a fourfold higher dosage than the reference vaccine. The prototype vaccine was found to be safe and equally well-tolerated as the reference vaccine at either dosage tested. The prototype vaccine induced mucosal IgA (fecal secretory IgA and intestine-derived IgA antibody secreting cell) responses to both LTB and CFA/I, as well as serum IgA and IgG antibody responses to LTB. Immunization with LCTBA resulted in about twofold higher mucosal and systemic IgA responses against LTB than a comparable dose of CTB. The higher dose of the prototype vaccine induced significantly higher fecal and systemic IgA responses to LTB and fecal IgA responses to CFA/I than the reference vaccine. These results demonstrate that CF over-expression and inclusion of the LCTBA hybrid protein in an oral inactivated ETEC vaccine does not change the safety profile when compared to a previous generation of such a vaccine and that the prototype vaccine induces significant dose dependent mucosal immune responses against CFA/I and LTB.


Subject(s)
Bacterial Toxins/metabolism , Cholera Toxin/metabolism , Enterotoxigenic Escherichia coli/immunology , Enterotoxins/metabolism , Escherichia coli Proteins/immunology , Escherichia coli Proteins/metabolism , Escherichia coli Vaccines/adverse effects , Escherichia coli Vaccines/immunology , Fimbriae Proteins/immunology , Adjuvants, Immunologic/genetics , Adjuvants, Immunologic/metabolism , Administration, Oral , Adult , Antibodies, Bacterial/analysis , Antibodies, Bacterial/blood , Bacterial Toxins/genetics , Cholera Toxin/genetics , Colicins , Double-Blind Method , Enterotoxins/genetics , Escherichia coli Proteins/genetics , Escherichia coli Vaccines/administration & dosage , Female , Fimbriae Proteins/genetics , Human Experimentation , Humans , Immunity, Mucosal , Immunoglobulin A/analysis , Immunoglobulin A/blood , Immunoglobulin G/blood , Male , Middle Aged , Vaccines, Inactivated/administration & dosage , Vaccines, Inactivated/adverse effects , Vaccines, Inactivated/immunology , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/adverse effects , Vaccines, Synthetic/immunology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL